Members-Only Resources
VIEW:
- POSTER
Office/Exam Room Educational Posters
December 9, 2024PROSTATE CANCERDOCUMENT
Cardio-Oncology DotPhrases for Electronic Medical Records
November 26, 2024COURSE
Navigating the Future: Growing Your Cardio-Oncology Clinic
November 14, 2024COURSE
Navigating the Future: Starting Your Cardio-Oncology Clinic
November 14, 2024VIDEO
Cardio-Oncology in Brazil | Brazilian Chapter of the International Cardio-Oncology Society (ICOS)
November 12, 2024PDFTOOL
El cáncer de mama y su corazón
November 4, 2024E-PUBPDF
Breast Cancer and Your Heart
October 17, 2024BREAST CANCERMEMBER PUBLICATIONPDF
Isolated Pericardial Effusion Without Associated Myocarditis in a Small-Cell Lung Cancer Patient Undergoing Atezolizumab Therapy
June 19, 2024FINANCIAL RETURNS
2023 Financial Return
June 8, 2024RESOURCES
Cardioprotective Potential of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Cancer Treated With Anthracyclines: An Observational Study
May 28, 2024COURSE
curso de idioma español
May 14, 2024PDF
Cardio-Oncology Facts for Nurses
April 10, 2024NURSINGRESOURCES
Preventing Anthracycline-Associated Heart Failure: What Is the Role of Dexrazoxane?: JACC: CardioOncology Controversies in Cardio-Oncology
April 6, 2024VIDEO
Finding Amyloidosis – Rachel & Nasir’s Story
April 4, 2024AMYLOIDOSISEXPERT CONSENSUS
The Compelling Need for a Cardiology and Oncology Partnership and the Birth of the International CardiOncology Society
March 28, 2024HISTORYRESOURCES
Proceedings From the Global Cardio-Oncology Summit The Top 10 Priorities to Actualize for CardioOncology
March 28, 2024RESOURCES
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building
March 28, 2024CLINICAL PRACTICERESOURCES
Tom Force (1951–2020) Our Dearest Friend, Our Mentor, and a Brilliant Cardiovascular Scientist
March 28, 2024HISTORYTOOL
Monitoring and Management of Cardio-Oncology Patients
March 28, 2024PATIENT MANAGEMENTTOOL
Khorana Risk Score for Venous Thromboembolism in Cancer Patient
March 28, 2024VIDEO
Monoclonal Antibodies Presentation Recording
March 28, 2024#N/A
Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
March 28, 2024CARDIOTOXICITYEXPERT CONSENSUS
Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement
March 28, 2024AMYLOIDOSISGUIDELINES
ICOP-Pharm: could the new paradigm bridge a gap in evidence raised by 2022 ESC guidelines on cardio-oncology?
March 28, 2024PHARMACYRESOURCES
Implementing a Cardiooncology Center of Excellence Nuts and Bolts
March 28, 2024CLINICAL PRACTICEVIDEO
IC-OS Force Award, Dent 2022
March 28, 2024T FORCE AWARDORGANIZATIONS
JACC: CardioOncology
March 28, 2024RESOURCES
Future steps in cardio‑oncology—a national multidisciplinary survey among healthcare professionals in the Netherlands
March 28, 2024INTERNATIONAL PERSPECTIVESTOOL
Drug Interaction Checker
March 28, 2024PHARMACYTOOL
Find Fellowships in Cardio-Oncology
March 28, 2024JOB OPPORTUNITIES, RECRUITINGGUIDELINES
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
March 28, 2024AMYLOIDOSISMEMBER PUBLICATION
Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive
March 28, 2024ORGANIZATIONS
ESC Council of Cardio-Oncology
March 28, 2024EXPERT CONSENSUS
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
March 28, 2024CARDIOTOXICITYRESOURCES
Developing a comprehensive Cardio-Oncology Program at a Cancer Institute: the Moffitt Cancer Center experience
March 28, 2024CLINICAL PRACTICEGUIDELINES
Clinical Practice and Research in Cardio-Oncology: Finding the “Rosetta Stone” for Establishing Program Excellence in Cardio-oncology
March 28, 2024CLINCAL PRACTICEEXPERT CONSENSUS
Cardio-Oncology Education and Training: JACC Council Perspectives
March 28, 2024CLINCAL PRACTICEEXPERT CONSENSUS
Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the International Cardio-Oncology Society (ICOS)
March 28, 2024IMAGINGEXPERT CONSENSUS
Cardiovascular Manifestations From Therapeutic Radiation A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society
March 28, 2024RADIATIONEXPERT CONSENSUS
Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary Specialty
March 28, 2024CLINICAL PRACTICEWEBSITE
Cancer.Net
March 28, 2024MEMBER PUBLICATION
and Out of the Hospital in Patients Admitted With COVID-19
March 28, 2024EXPERT CONSENSUS
An International Survey of Health Care Providers Involved in the Management of Cancer Patients Exposed to Cardiotoxic Therapy
March 28, 2024CARDIOTOXICITYRESOURCES
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio- Oncology Society
March 28, 2024CARDIOTOXICITYRESOURCES
Cancer and War in Ukraine How The World Can Help Win This Battle
March 28, 2024INTERNATIONAL PERSPECTIVESGUIDLEINES
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)”
March 28, 2024GUIDELINES
Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease: JACC Scientific Expert Panel
March 24, 2024CARDIAC DISEASEGUIDELINES
Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease: JACC Scientific Expert Panel
March 24, 2024CARDIAC DISEASESPANISH LANGUAGE
Sobre el grupo
March 1, 2024SPANISH LANGUAGESPANISH LANGUAGE
Spanish Language Graduate Level Course
January 28, 2024SPANISH LANGUAGESPANISH LANGUAGE
Programa de formación en Cardio-Onco-Hematología #COH19
January 28, 2024SPANISH LANGUAGEEXPERT CONSENSUS
Seeing the Forest for the Trees: Recognizing Potential Amyloidosis
January 23, 2024AMYLOIDOSIS, CANCER SURVIVORSHIP, PATIENT MANAGEMENT, PATIENT STORIESE-NEWSLETTER
2024 Annual Newsletter
January 1, 2024E-NEWSLETTER
2023 Annual Newsletter
January 1, 2024VIDEO
Cancer Survivor Stories: Kreena’s Story
August 14, 2023BREAST CANCERRESOURCES
Cardio-Oncology Stories: Sofia’s Story
June 30, 2023CHILDHOOD CANCERSLIDESHOW
Topics in Cardio-Oncology: Advanced Imaging in Cardio-Oncology
May 1, 2023IMAGINGMEMBER PUBLICATION
ICOP-Pharm: could the new paradigm bridge a gap in evidence raised by 2022 ESC guidelines on cardio-oncology?
March 14, 2023MEMBER PUBLICATION
Incidental right atrial mass in a patient with secondary pancreatic cancer: A case report and review of literature
February 16, 2023RESOURCES
Cardio-Oncology Guidelines and Strength of the Evidence
February 5, 2023SPANISH LANGUAGE
Programa de formación en Cardio-Onco-Hematología #COH18
January 28, 2023SPANISH LANGUAGEE-NEWSLETTER
2022 Annual Newsletter
January 1, 2023FINANCIAL RETURNS
2022 Financial Return
December 31, 2022GUIDELINES
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-on
November 1, 2022CARDIO-ONCOLOGHY GUIDELINEMEMBER PUBLICATION
Global pattern of cardiovascular disease management in patients with cancer and impact of COVID-19 on drug selection: IRAQ—IC-OS survey-based study
September 21, 2022VIDEO
Topics: Platinum Agents: Clsplatin, Carboplatin & Oxaliplain
September 20, 2022PLATINUM AGENTSCARTOON
Talking about Car-T Cells
July 1, 2022CAR-TMEMBER PUBLICATION
Edoxaban: front-line treatment for brachiocephalic vein thrombosis in primitive mediastinal seminoma
April 18, 2022MEMBER PUBLICATION
Novel Biomarkers and Therapeutic Discoveries for Cardiovascular Diseases
March 15, 2022VIDEO
Topics in Cardio-Oncology: Cardiomyopathy
March 1, 2022CARDIOMYOPATHYMEMBER PUBLICATION
Mitochondrial Redox in Cardio-Metabolic Disease and Cardio- Oncology
February 10, 2022VIDEO
Topics: Immune check point inhibitors cardiovascular effects
February 1, 2022IMMUNCE CHECKPOINT INHBITORSE-NEWSLETTER
2021 Annual Newsletter
January 1, 2022FINANCIAL RETURNS
2021 Financial Returns
December 31, 2021SLIDESHOW
Topics in Cardio-Oncology:Cancer Survivorship Slides
December 1, 2021CANCER SURVIVORSHIPVIDEO
Topics: BCR-ABL Tyrosine Kinase Inhibitors
December 1, 2021TYROSINE KINASE INHIBITORSVIDEO
Topics in Cardio-Oncology: Pre-Op Assessment of Oncological Surgeries
December 1, 2021PRE-OPERATIVE ASSESSMENTVIDEO
Topics in Cardio-Oncology: Amyloidosis
November 1, 2021AMYLOIDOSISVIDEO
Topics in Cardio-Oncology: Cardiovascular Effects of Car-T Cell Therapy
November 1, 2021CAR-TVIDEO
Topics: 5 FU and Cardiovascular Toxicity
November 1, 20215 FUVIDEO
Topics: Hormone Depravation Therapy
November 1, 2021HORMONE DEPRAVATION THERAPYVIDEO
Topics in Cardio-Oncology: Venous and arterial thromboembolism in cancer patients (vascular toxicities)
November 1, 2021VTEKNOWLEDGE BASE
Heart Problems Caused by Cancer Treatment
October 1, 2021MEMBER PUBLICATION
Cardio-Oncology Educational Program: National Survey as the First Step to Start
August 2, 2021MEMBER PUBLICATION
Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio study
July 29, 2021MEMBER PUBLICATION
Prognostic Role of Cardiopulmonary Exercise Testing in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Treated With Tafamidis
July 16, 2021MEMBER PUBLICATION
Early Tracking of Radiation-Induced Cardiotoxicity: Paradigm, Pragmatism, and Possibilities∗
June 3, 2021VIDEO
Update on Current Therapy for AL Amyloidosis
April 29, 2021AMYLOIDOSISVIDEO
When to Suspect and How to Diagnose Amyloidosis
April 29, 2021AMYLOIDOSISVIDEO
Developing Therapy for ATTR amyloidosis
April 29, 2021AMYLOIDOSISVIDEO
The Principles for Pathology Confirmation of Amyloidosis and Significance of Subtyping
April 29, 2021AMYLOIDOSISVIDEO
Renal Amyloidosis: Presentations, Diagnosis and Management
April 29, 2021AMYLOIDOSISVIDEO
What do the Elevated Protein Levels Mean in my Patient with Myeloma and/or AL Amyloidosis?
April 28, 2021AMYLOIDOSISVIDEO
Management Strategies for GI Involvement with Amyloidosis
April 28, 2021AMYLOIDOSISVIDEO
Neurologic involvement in amyloidosis
April 28, 2021AMYLOIDOSISVIDEO
Management of cardiac issues in patients with amyloidosis
April 28, 2021AMYLOIDOSISWEBINAR RECORDINGS
Pediatrics Cardio Oncology Webinars
April 20, 2021PEDIATRICSMEMBER PUBLICATION
Thromboembolic risk management in cancer patients
April 14, 2021MEMBER PUBLICATION
How can we manage the cardiac toxicity of immune checkpoint inhibitors?
April 1, 2021MEMBER PUBLICATION
Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment—A Cardio-Oncology Study
March 31, 2021VIDEO
Discussing our cardio-oncology guideline | Dr Rebecca Dobson and Dr Arjun Ghosh
March 26, 2021IMAGJNGVIDEO
Publishing the cardio-oncology guideline | Professors Mark Monaghan and Tom Marwick
March 16, 2021IMAGING GUIDELINE
BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab
March 16, 2021VIDEO
Is There any Concern with COVID-19 and Treatment for AL Amyloidosis?
March 6, 2021AMYLOIDOSISMEMBER PUBLICATION
Microtubule Inhibitors and Cardiotoxicity
February 13, 2021MEMBER PUBLICATION
Effect of Discontinuing vs Continuing Angiotensin-Converting
January 19, 2021MEMBER PUBLICATION
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
January 7, 2021E-NEWSLETTER
2020 Annual Newsletter
January 1, 2021FINANCIAL RETURNS
2020 Financial Return
December 31, 2020MEMBER PUBLICATION
Heart disease and breast cancer
November 26, 2020BREAST CANCERMEMBER PUBLICATION
Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin
October 28, 2020BREAST CANCERMEMBER PUBLICATION
Hypertensive Cardiotoxicity in Cancer Treatment—Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies—Epidemiology, Incidence, and Pathophysiology
October 18, 2020MEMBER PUBLICATION
Florida Inter-Specialty Collaborative Project to Improve Cardio-Oncology Awareness and Identify Existing Knowledge Gaps
September 15, 2020EXPERT CONSENSUS
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
September 5, 2020MEMBER PUBLICATION
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
September 1, 2020VIDEO
JACC: CardioOncology Video Case Presentation: Cardiotoxicity During HER2-Targeted Therapy
August 24, 2020CASE PRESENTATIONMEMBER PUBLICATION
Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
July 21, 2020JOURNAL
Cardiovascular disease and asymptomatic childhood cancer survivors: Current clinical practice
May 13, 2020CHILDHOOD CANCERMEMBER PUBLICATION
Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis
May 4, 2020MEMBER PUBLICATION
Impact of Stopping Trastuzumab in Early Breast Cancer: A Population-Based Study in Ontario, Canada
April 28, 2020BREAST CANCERMEMBER PUBLICATION
Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer
April 27, 2020MEMBER PUBLICATION
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
March 30, 2020MEMBER PUBLICATION
Vascular toxic effects of cancer therapies
March 26, 2020